Heather M. Scobie, Nino Khetsuriani, Rania A. Tohme, Anna M. Acosta, Steven G.F. Wassilak & Walter A. Orenstein. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1117
1141.e16
.
Itzhak Brook. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1013
1017.e1
.
Dawn B. Beaulieu, Ashwin N. Ananthakrishnan, Christopher Martin, Russell D. Cohen, Sunanda V. Kane & Uma Mahadevan. (2018) Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Clinical Gastroenterology and Hepatology 16:1, pages 99-105.
Crossref
Itzhak Brook. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
995
999.e1
.
Martha H. Roper, Steven G.F. Wassilak, Heather M. Scobie, Alison D. Ridpath & Walter A. Orenstein. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1052
1079.e18
.
Martha H. Roper, Steven G.F. Wassilak, Tejpratap S.P. Tiwari & Walter A. Orenstein. 2013. Vaccines. Vaccines
746
772
.
Itzhak Brook. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
966
970.e1
.
Steven G.F. Wassilak, Martha H. Roper, Katrina Kretsinger & Walter A. Orenstein. 2008. Vaccines. Vaccines
805
839
.
Itzhak Brook. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
956
959
.
Torben Ek, Lotta Mellander, Mirjana Hahn-Zoric & Jonas Abrahamsson. (2004) Intensive Treatment for Childhood Acute Lymphoblastic Leukemia Reduces Immune Responses to Diphtheria, Tetanus, and Haemophilus influenzae Type b. Journal of Pediatric Hematology/Oncology 26:11, pages 727-734.
Crossref
B Hejdeman, A-C Leandersson, E-L Fredriksson, E Sandstrom, B Wahren & G Bratt. (2003) Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up. HIV Medicine 4:2, pages 101-110.
Crossref
J. Vidal. (2003) Vacunación antitetánica. ¿Debe modificarse la pauta de una dosis de recuerdo cada 10 años?. Vacunas 4:1, pages 15-17.
Crossref
J. Batall, L. Urbiztondo, M. Martínez y & M. Boldú. (2003) Reactogenicidad declarada de la vacunación antitetánica en la población adulta de Cataluña. Vacunas 4:1, pages 9-14.
Crossref
ROSE-MARIE CARLSSON, BO A. CLAESSON, EVA FAGERLUND, NINA KNUTSSON & CLAUS LUNDIN. (2002) Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy. The Pediatric Infectious Disease Journal 21:6, pages 535-541.
Crossref
Marcela Pasetti, Patricia Eriksson, Marcela Manghi & F. Ferrero. (1997) Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children. Infection 25:6, pages 339-345.
Crossref
MARCELA F. PASETTI, JOSÉ DOKMETJIAN, PATRICIA V. ERIKSSON, MARCELA A. MANGHI, MARÍA LUISA BRERO & FERNANDO FERRERO. (2011) Structure and Protective Capacity of Tetanus and Diphtheria Antibodies Produced During Human Pregnancy and Transferred to New‐Born. American Journal of Reproductive Immunology 37:3, pages 250-256.
Crossref